A phase I trial of intravenous vesicular stomatitis virus expressing thyroidal sodium iodide symporter (NIS) and human interferon beta (hIFNβ) in metastatic or recurrent endometrial cancer
Publication date: December 2026 Source: Gynecologic Oncology, Volume 215 Author(s): Simrit K. Warring, Kah-Whye Peng, Pamela J. Atherton, Erik J. Asmus, Lianwen Zhang, Courtney L. Erskine, Yi-ying Ma, Nandakumar Packiriswamy, Megan E. Grudem, Carolyn M. Klampe, Saravut J. Weroha, Aminah Jatoi, Andrea E. Wahner Hendrickson, Paula Gill, Gretchen E. Glaser, Amanika Kumar, Carrie L. Langstraat, Matthew S. Block, Jamie N. Bakkum-Gamez
A phase I trial of intravenous vesicular stomatitis virus expressing thyroidal sodium iodide symporter (NIS) and human interferon beta (hIFNβ) in metastatic or recurrent endometrial cancer. // Gynecologic Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0090825826021815?dgcid=rss_sd_all
A phase I trial of intravenous vesicular stomatitis virus expressing thyroidal sodium iodide symporter (NIS) and human interferon beta (hIFNβ) in metastatic or recurrent endometrial cancer. Gynecologic Oncology. https://www.sciencedirect.com/science/article/pii/S0090825826021815?dgcid=rss_sd_all
“A phase I trial of intravenous vesicular stomatitis virus expressing thyroidal sodium iodide symporter (NIS) and human interferon beta (hIFNβ) in metastatic or recurrent endometrial cancer.” Gynecologic Oncology.
@article{article47174,
title = {A phase I trial of intravenous vesicular stomatitis virus expressing thyroidal sodium iodide symporter (NIS) and human interferon beta (hIFNβ) in metastatic or recurrent endometrial cancer},
journal = {Gynecologic Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0090825826021815?dgcid=rss_sd_all}
}